CA0717051076
© BusinessWire
12.12.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated a $2,802,125,000 tranche (the “Replacement Term Loans”) of new term B loans, the proceeds of which will be used to refinance all of its outstandi...
Themefolio
Profiler
Peergroup
© BusinessWire
18.11.2025
BLCO
LISTED
TSX
Bausch + Lomb to Participate in Citi Global Healthcare Conference
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in a fireside chat at the 2025 Citi Global Healthcare Conference on Wedn...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
BLCO
LISTED
TSX
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will outline the next chapter of its evolution today during an investor day event at the New York Stock Exchange.
Leading Through Reinvention
Over the past few years, Bausch + Lomb has undergone a complete tran...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
10.11.2025
BLCO
LISTED
TSX
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program, created in collaboration with international recycling leader TerraCycle®, has collected a total of 691,180 pounds, or 114,037,136 units, of used conta...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
03.11.2025
BLCO
LISTED
TSX
Bausch + Lomb to Hold Investor Day on Nov. 13
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock Exchange.
Chairman and CEO Brent Saunders will provide an update on the company’s transformation and strategic outlook, and Executive Vi...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Third-Quarter 2025 Results
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2025 financial results.
“We’re delivering on the vision we laid out in 2023, with a base business engine that continues to hum and steady introduction of innovative products acro...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
BLCO
LISTED
TSX
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 29, 2025. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All material...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the American Journal of Ophthalmology has published results of the pivotal U.S. clinical trial of the enVista Envy novel full visual range intraocular lens. The study compared visual, refractiv...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Clinical Ophthalmology has published results from an investigator-initiated study which evaluated the effectiveness of XIIDRA (lifitegrast ophthalmic solution) 5% in alleviating end-of-day (EOD) eye...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
BLCO
LISTED
TSX
Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of ASANA gas permeable (GP) lenses. ASANA offers eye care professionals a versatile, all-in-one comprehensive GP portfolio, featuring spherical, aspheric, toric, multifocal, multifoc...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Board Changes
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amended and Restated Director Appointment and Nomination Agreement, dated as of June 21, 2022, by and among the company and Mr. Carl C. Icahn and certain of his affiliates, terminated pursu...
Themefolio
Profiler
Peergroup
© BusinessWire
14.08.2025
BLCO
LISTED
TSX
Bausch + Lomb to Participate in Upcoming Investor Conferences
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that members of its management team will participate in two investor conferences in September:
J.P. Morgan European Leveraged Finance Conference
September 3, 2025, London, U.K.
Morgan Stanley...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
30.07.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Second-Quarter 2025 Results
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2025 financial results.
“Our continued growth speaks to the breadth and depth of our portfolio and is driven by a mix of hero products and a steady stream of new introductions a...
Themefolio
Profiler
Peergroup
© BusinessWire
29.07.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free redness reliever eye drops compared to LUMIFY redness reliever...
Themefolio
Profiler
Peergroup
© BusinessWire
01.07.2025
BLCO
LISTED
TSX
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today launched “Eyes Tell the Story: The Impact of Dry Eye.” The campaign aims to educate about dry eye through personal stories, compelling imagery and new survey data, and encourages people with symptoms to speak...
Themefolio
Profiler
Peergroup
© BusinessWire
30.06.2025
BLCO
LISTED
TSX
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July 30, 2025. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materia...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the “Issuers”), have closed the upsized offering of €675 mill...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
BLCO
LISTED
TSX
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz continues its investigation of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAUSCH + LOMB CORPORATION (BLCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUIN...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
BLCO
LISTED
TSX
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith continues its investigation on behalf of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BAUSCH + LOMB CORPORATION (BLCO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOU...
Themefolio
Profiler
Peergroup
© BusinessWire
20.06.2025
BLCO
LISTED
TSX
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAUSCH + LOMB CORPORATION (BLCO)...
Themefolio
Profiler
Peergroup
© BusinessWire
18.06.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the “Issuers”), have priced the offering of €675 million aggr...
Themefolio
Profiler
Peergroup
© BusinessWire
10.06.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the “Issuers”), have launched an offering of €600 million agg...
Themefolio
Profiler
Peergroup
© BusinessWire
06.06.2025
BLCO
LISTED
TSX
BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or “the Company”) (NYSE: BLCO) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or...
Themefolio
Profiler
Peergroup
© BusinessWire
04.06.2025
BLCO
LISTED
TSX
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink Nourish Lubricating eye drops and Blink Boost Lubricating eye drops. Both products are preservative-free, contact-lens friendly and uniquely formulated to provide hydration...
Themefolio
Profiler
Peergroup
© BusinessWire
22.05.2025
BLCO
LISTED
TSX
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky is scheduled to participate in the 2025 Jefferies Global Healthcare Conference in New York City on June 4, 2025, at 7:35 a.m. ET.
A live webcast of the c...
Themefolio
Profiler
Peergroup
© BusinessWire
21.05.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2025 Annual Meeting of Shareholders (the “Annual Meeting”) held on May 21, 2025. Detailed results of the vote fol...
Themefolio
Profiler
Peergroup
© BusinessWire
21.05.2025
BLCO
LISTED
TSX
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of LUMIFY Preservative Free redness reliever eye drops, the first and only preservative-free over-the-counter eye drops with low-dose brimonidine tartrate 0.025% that relieve redness...
Themefolio
Profiler
Peergroup
© BusinessWire
14.05.2025
BLCO
LISTED
TSX
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Zenlens CHROMA HOA scleral contact lenses. Designed to correct advanced higher-order aberrations (HOA), this custom, wavefront-guided scleral lens technology delivers enhanced vis...
Themefolio
Profiler
Peergroup
© BusinessWire
09.05.2025
BLCO
LISTED
TSX
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAUSCH...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
BLCO
LISTED
TSX
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BAUSCH + LOMB CORPORATION (BLCO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
BLCO
LISTED
TSX
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAUSCH + LOMB CORPORATION (BLCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
BLCO
LISTED
TSX
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of vision intraocular lens (IOL). The preloaded IOL provides patients with natural, continuous vision, from distance to near. Today’s announcement reinfor...
Themefolio
Profiler
Peergroup
© BusinessWire
30.04.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces First-Quarter 2025 Results
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quarter 2025 financial results.
“Our core business is performing well, and we remain focused on positioning the company for long-term, profitable growth,” said Brent Saunders, chairman an...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
BLCO
LISTED
TSX
Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has identified the event that led to its recent voluntary recall of intraocular lenses (IOLs) on the enVista platform. Now that the cause and affected lots have been confirmed, the company will r...
Themefolio
Profiler
Peergroup
© BusinessWire
21.04.2025
BLCO
LISTED
TSX
Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 103,169,500 units, or 625,026 pounds, of used contact lenses, eye care and lens care materials in...
Themefolio
Profiler
Peergroup
© BusinessWire
27.03.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses (IOLs) on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
BLCO
LISTED
TSX
Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All mater...
Themefolio
Profiler
Peergroup
© BusinessWire
17.03.2025
BLCO
LISTED
TSX
Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Arise, a lens fitting system that uses intelligent, cloud-based technology to streamline the orthokeratology lens design process. Arise seamlessly syncs directly with topographers...
Themefolio
Profiler
Peergroup
© BusinessWire
19.02.2025
BLCO
LISTED
TSX
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and full-year 2024 financial results.
“Underpinning our recent success is a commitment to long-term, profitable growth,” said Brent Saunders, chairman and CEO, Bausch + Lomb. “Ou...
Themefolio
Profiler
Peergroup
© BusinessWire
06.02.2025
BLCO
LISTED
TSX
Bausch + Lomb Provides Update on Potential Sale
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following update on a potential sale, which was disclosed in December 2024 following a regulatory request:
“Taking Bausch + Lomb private with a third-party buyer was one of several options being explor...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2025
BLCO
LISTED
TSX
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial results on Wednesday, February 19, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a bus...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
BLCO
LISTED
TSX
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate has acquired Whitecap Biosciences, LLC, which is currently developing two innovative therapies for potential use in glaucoma and geographic atrophy (GA). The acquisition strengthens Bau...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
BLCO
LISTED
TSX
Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses (IOLs) in the European Union after receiving a CE Mark late last year. enVista Aspire combines novel Intermediate O...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2025
BLCO
LISTED
TSX
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national nonprofit organization dedicated to curing glaucoma, are launching the second annual “Faces of Glaucoma” campaign. The campaign, which will highlight diverse patie...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2025
BLCO
LISTED
TSX
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, M.D., will participate in a company presen...
Themefolio
Profiler
Peergroup
© BusinessWire
12.12.2024
BLCO
LISTED
TSX
Bausch + Lomb Responds to Rumors of a Potential Sale
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO):
“The Bausch + Lomb Board of Directors authorized management and its advisors to explore a poten...
Themefolio
Profiler
Peergroup
© BusinessWire
11.12.2024
BLCO
LISTED
TSX
Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that an affiliate has acquired Elios Vision, Inc., developer of the ELIOS™ procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser. The...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2024
BLCO
LISTED
TSX
Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 94,119,275 units*, or 569,743 pounds, of used contact lenses, eye care and lens care materials in...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2024
BLCO
LISTED
TSX
Bausch + Lomb Announces Third-Quarter 2024 Results
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2024 financial results.
“Our focus on execution continues to drive growth, with significant opportunity ahead,” said Brent Saunders, chairman and CEO, Bausch + Lomb. “We’re in the...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2024
BLCO
LISTED
TSX
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has approved the enVista® Envy™ full range of vision intraocular lens (IOL), which offers a continuous range of vision with excellent dysphotopsia toleranc...
Themefolio
Profiler
Peergroup
© BusinessWire
09.10.2024
BLCO
LISTED
TSX
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2024 financial results on Wednesday, October 30, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. Al...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2024
BLCO
LISTED
TSX
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
News Preview
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Opal, a digital e-commerce marketplace. Designed to help maximize efficiencies for eye care practices while enhancing the patient experience, Opal provides a streamlined ordering...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
